NextFin News - Ángel Escribano, the Spanish defense entrepreneur forced out as chairman of state-backed Indra Sistemas in April after a conflict-of-interest fight over merging his family firm into the national champion, is plotting an initial public offering of that same family business, Escribano Mechanical & Engineering (EM&E). The move converts a governance defeat into a public-market payday - and tests how far Europe's rearmament boom can carry a dynastic defense contractor when it stands alone.
The Exit That Set the Stage
The sequence matters. In January 2025, the government of Pedro Sánchez installed Escribano as executive chairman of Indra, Spain's flagship defense and technology group, in which the state owns a 28% stake through the SEPI holding fund. From the outset, Escribano pushed to combine Indra with EM&E, the artillery and armored-vehicle specialist he founded with his brother Javier - a deal he presented as the consolidation Spain's defense industry needed.
By mid-March 2026, SEPI president Belén Gualdá González had publicly declared that the conflict of interest had to be "resolved" before any merger could proceed. Less than a day later, EM&E withdrew from the negotiations, saying the circumstances no longer existed. Indra's shares fell more than 17% early that session before trimming losses. Two weeks after that, on April 1, 2026, Escribano resigned as chairman.
"The events of recent weeks have created a situation that, in addition to taking a personal toll, threatens to undermine the goals that have driven me from day one and that I consider essential for the future of Indra and the industry," Escribano wrote in his resignation letter to the board. "I cannot allow my continued presence to jeopardize the company's stability."
On May 5, 2026, EM&E completed the financial uncoupling: it sold its entire 14.3% stake in Indra - roughly 25.26 million shares - through an accelerated placement valued at approximately €1.32 billion at market prices. EM&E had been Indra's second-largest shareholder, behind only SEPI. The family had entered the register modestly: in May 2023 it paid more than €65 million for a 3% stake. The placement, filed with Spain's market regulator, also triggered the resignation of Javier Escribano as a proprietary director of Indra, removing the family from the boardroom entirely.
Now, with the Indra chapter closed and the cash realized, the family is preparing to take EM&E itself public. The valuation the family has put on the business - at least €2.3 billion, based on applying a 12-to-15-times EBITDA multiple to its €195 million of 2025 earnings before interest, taxes, depreciation and amortization - sits well above the €1 billion to €1.5 billion range produced by the independent commission during the merger talks. A listing near the family's figure would value EM&E at more than 35 times what the Escribanos paid for their original 3% foothold in Indra just over three years ago.
What EM&E Actually Sells - and Who Buys It
Understanding the IPO requires understanding the asset. EM&E is not a paper contractor. It builds the VCR 8x8 Dragon, the Spanish Army's new wheeled armored combat vehicle, and the Dragón family of vehicles has been rolling off the line in Córdoba at an industrial cadence that few European land-systems programs have matched. The company also makes artillery systems, mortar carriers, and unmanned ground vehicles, and has moved into counter-unmanned-aircraft systems - the fastest-growing slice of the defense budget after the drone warfare lessons of Ukraine.
Crucially, EM&E has already proven it can win without the Indra umbrella. It has secured export contracts in the Middle East and signed a joint venture with UAE-based EDGE Group, a marker of international reach that a domestic-only supplier could not claim. That export optionality is the family's answer to the concentration risk: if Spanish procurement slows, the growth story migrates to foreign buyers rearming at the same pace.
But the Spanish state remains the anchor. Indra has been a major beneficiary of the government's push to lift defense spending above 2% of GDP, and many tenders worth billions of euros have been allocated to joint ventures between Indra and EM&E. As a private company, EM&E could sit on both sides of those consortia while its co-owner chaired the lead partner. As a listed company, every euro of that arrangement becomes a line item in a prospectus - and a potential line of attack for a losing bidder.
Why the IPO Route, Not the Merger
The pivot from merger to listing is more than a change of venue. A related-party acquisition of EM&E by Indra would have required independent valuations, shareholder votes, and relentless scrutiny of whether the Escribano brothers were selling their own assets to a company they controlled. The proposed deal structure made the tension unavoidable: Indra was considering a capital increase of around €1 billion to finance the acquisition, which the Escribano family would have subscribed to in bulk, lifting their stake above 20% and handing them decisive influence over the combined group. An IPO sidesteps that entire governance gauntlet. The market, not a conflicted board, sets the price - and in Europe's current defense cycle, the market is in a generous mood.
Spain has committed to lifting defense spending above 2% of GDP, and in April 2025 announced 31 Special Modernization Programs worth around €3.8 billion, many flowing to domestic contractors. Indra, as the national leader, has ridden that wave: its backlog reached €20.53 billion in the first half of 2026, up 117% from a year earlier, on order intake of €5.01 billion, up 58%. The company raised its 2026 guidance to more than €7 billion in revenue and more than €700 million in EBIT. Indra's shares have returned 74% over the past year and nearly 600% over five years, trading at roughly 23 times trailing earnings - a premium that did not exist before the rearmament cycle began.
EM&E sits squarely in the same flow. The family's argument to investors is straightforward: they can capture the full rearmament multiple on EM&E's own earnings without sharing the upside with Indra's slower digital-services and air-traffic businesses, and without the conglomerate discount that has long attached to Indra's mixed portfolio.
There is also a timing calculation. Defense valuations across Europe are at or near record levels, and the pipeline of public listings in the sector remains thin. Being among the first pure-play Spanish defense contractors to list gives EM&E a scarcity premium - but only if the window stays open. IPO markets are cyclical by nature; a rearmament story priced for perfection leaves little room for a procurement delay or a political shift.
The Valuation Gap Is the Risk
The distance between the valuation benchmarks is where the deal's tension sits. During the merger talks, an independent commission was tasked with producing a valuation report, with estimates ranging between €1 billion and €1.5 billion. The family has consistently argued the business is worth more - Javier Escribano said in April 2025 that the company was not for sale and was worth over €1 billion, while Spanish media have reported the family's internal view at €2.3 billion to €2.34 billion, derived from a 12-to-15-times EBITDA multiple applied to €195 million of 2025 EBITDA.
An IPO at the top of that range would price EM&E at more than twice the midpoint of the independent assessment that sank the merger. That gap can be justified only if public investors believe EM&E's order book will keep compounding at wartime-adjacent rates. It cannot be justified by the merger synergies the Indra deal would have created - those synergies die with the IPO.
Indra's own market signal is instructive. After the merger collapsed and Escribano exited, the stock did not crater permanently. As of September 8, 2026, Indra closed at €58.04, up 0.24% on the day, with a market capitalization of about €10.16 billion - near its 52-week high of €66.15 and far above its 52-week low of €32.38. Year to date it has returned 20%, and in the first half of 2026 it posted revenue of €3.18 billion, up 30%, with net income of €219 million and an EBIT margin of 9.9%. The market has concluded that Indra does not need the Escribanos - and that EM&E can stand alone. Both conclusions are bullish for the IPO, but only if execution holds.
What the Market Is Pricing In - and What It Is Not
The conventional read is simple: European rearmament is a multi-year tailwind, defense contractors are scarce, and EM&E has real products in real service. That is all true, and it is all priced in. The second-order question investors are not asking loudly enough is what happens to the political relationship.
As a private supplier, EM&E could win joint contracts with Indra while its co-owner chaired the bigger company - an arrangement that drew conflict-of-interest complaints and ultimately killed the merger. As a public company, every contract award will be visible, contestable, and politically charged. The same government that pushed Escribano out of Indra will be the IPO's anchor customer. A change in administration, a procurement review, or a competitor's challenge to a tender could compress the multiple faster than any earnings miss.
The counter-thesis runs further. Europe's defense spending surge is a structural shift, not a cyclical bounce - the war in Ukraine, a deteriorating strategic environment, and sustained U.S. pressure on NATO allies have reset baseline budgets. On that view, EM&E is listing into a decade-long expansion, and today's "rich" valuation will look cheap in hindsight. This argument has institutional backing: defense ministries across the continent have embedded multi-year procurement plans that survive electoral cycles, and Spain's 31 modernization programs are legislated commitments, not discretionary spending. Germany's €100 billion special fund and NATO's 2% floor have turned defense from a discretionary budget line into a planning constant.
But even within a structural upcycle, entry valuation matters. A company priced at the top of its independent valuation range, with no merger synergies and a single dominant customer, has a narrower margin of safety than the headline tailwind suggests. The rearmament cycle is structural; the multiple attached to it is not. History is littered with excellent industries that were terrible investments because the entry price assumed perfection - and defense, with its lumpy multi-year contracts, is especially unforgiving of timing errors.
The falsifying signal is concrete: if Spain's defense procurement allocation for 2027 comes in flat or below the 2026 level - or if EM&E loses a major tender to a competitor such as General Dynamics Santa Bárbara Sistemas - the scarcity-premium thesis breaks, and the IPO would have been timed at the top of the cycle rather than the start of a decade.
Who Benefits, Who Is Exposed
Short term, the IPO benefits the Escribano family first: it crystallizes a fortune built on a €65 million entry into a stake that generated roughly €1.32 billion in proceeds, and then compounds it through a public valuation of the operating business. It also benefits Spanish defense-sector sentiment - a successful listing would validate the entire domestic supply chain and could unlock follow-on offerings from other private contractors sitting on government order books.
Indra is the ambiguous case. On one hand, losing the merger means losing EM&E's artillery and armored-vehicle capabilities just as land-systems demand is peaking. On the other, Indra is freed from the governance cloud that depressed its shares through the spring of 2026, and its new non-executive chairman, Ángel Simón, can proceed without the conflict hanging over the boardroom. The shareholder base that backed Escribano - including T. Rowe Price, Amber Capital, and Third Point, which had taken positions during his chairmanship - is now free to reassess Indra on pure execution rather than governance drama. The stock's recovery to €58 - near its 52-week high - suggests investors have already made that trade.
The exposed party is the public investor buying the IPO. They get a pure play on Spanish rearmament without the diversification of Indra's air-traffic, mobility, and digital businesses - and without the state's 28% anchor stake providing a governance backstop. In a sector where politics and procurement are the same thing, that is a concentrated bet.
What to Watch
The IPO timeline, size, and advisor lineup have not been disclosed, and the family has not commented publicly on the listing plans. The concrete signals to track: the prospectus valuation versus the €1 billion to €1.5 billion independent range; the size of the free float; and whether SEPI or any sovereign fund takes a cornerstone position, which would signal state comfort with the Escribanos' return to the market.
Scenarios: the base case is a listing in 2027 at a valuation between €1.5 billion and €2 billion, trading up on debut as defense funds chase scarce exposure. The upside case is a €2 billion-plus debut on a wave of European defense allocations, making EM&E the benchmark Spanish defense equity. The downside case is a postponed or downsized offering if procurement headlines turn negative or if the broader IPO window closes on rate or growth fears.
Europe's rearmament is real, and it is lasting. But the Escribano IPO is a reminder that structural tailwinds do not guarantee structural returns - the family that was pushed out of the state champion is now asking the market to pay a premium that the state's own advisers said was too high. If public investors agree, the rearmament boom has produced its first dynastic fortune. If they do not, the conflict-of-interest fight will have ended exactly where it began: with the Escribanos on the outside, and the state still holding the contracts.
Explore more exclusive insights at nextfin.ai.
